SCM
XFOR icon

Stonepine Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History

Stonepine Capital Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Sell
335,309
-258,264
-44% -$967K 1.22% 29
2025
Q4 		$2.37M Sell
593,573
-462,765
-44% -$1.68M 1.88% 19
2025
Q3 		$3.61M Buy
+1,056,338
New +$2.72M 2.94% 10
2023
Q4 		– Sell
-175,790
Closed -$5.75M – 22
2023
Q3 		$5.75M Buy
175,790
+22,281
+15% +$972K 1.91% 13
2023
Q2 		$8.93M Buy
+153,509
New +$7.89M 3.22% 10

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return